Gaudium IVF and Women Health Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

Circuit Event and Unfilled Demand

The stock hit its upper circuit price limit of Rs 122.74, representing a 5.0% gain within the 5% price band allowed for the day. This ceiling effectively froze trading at the peak price, signalling that demand exceeded what the price band could accommodate. The total traded volume was 0.9534 lakh shares, with a turnover of ₹1.16 crore. The narrow intraday range between Rs 117.01 and Rs 122.74 suggests the stock spent much of the session near the upper limit, a typical pattern when circuits are hit. Gaudium IVF and Women Health Ltd’s upper circuit day reflects a scenario where buyers were willing to pay more, but the exchange’s price band capped the move, leaving unfilled demand on the table — what does the full demand picture look like for Gaudium IVF once the circuit unlocks and normal trading resumes?

Delivery and Volume Analysis

Delivery volumes tell a more nuanced story. On 3 Jul 2026, the last available delivery data, the stock saw 8,250 shares delivered, which was down 41.8% against the 5-day average delivery volume. This decline in delivery volume during a circuit day suggests that the buying pressure may be more speculative or intraday-driven rather than backed by long-term accumulation. Volume on a circuit day is mechanically suppressed because the price lock reduces liquidity, which means demand likely exceeded what the traded volume reflects. However, the falling delivery volume raises questions about the sustainability of the move — is this surge driven by conviction or thin liquidity? — the delivery data is the most revealing metric on a circuit day.

Moving Averages and Trend Context

Technically, Gaudium IVF and Women Health Ltd is trading below all major moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This indicates that the stock remains in a broader downtrend despite the upper circuit move. The circuit day thus appears to be a short-term spike rather than a breakout confirmed by trend-following indicators. The weighted average price was closer to the low of the day, reinforcing the notion that the rally was capped and that selling pressure may still be present. does the technical picture suggest a genuine recovery or a relief rally that will fade at the moving averages?

Liquidity and Market Capitalisation Context

With a market capitalisation of approximately ₹893.39 crore, Gaudium IVF and Women Health Ltd is classified as a micro-cap stock. Liquidity remains a critical factor here: the stock is liquid enough for a trade size of just ₹0.03 crore based on 2% of the 5-day average traded value. This limited liquidity means that even relatively small orders can move the price significantly, and the upper circuit lock may reflect thin order books rather than broad-based demand. For investors, this liquidity risk is as important as the momentum signal — should you be chasing a micro-cap with such constrained liquidity?

Intraday Price Action

The intraday range was relatively narrow, with the stock moving between Rs 117.01 and Rs 122.74. The upper circuit was hit late in the session, which is typical for stocks where buying interest intensifies as the day progresses. The weighted average price being closer to the low price indicates that a significant portion of volume traded at lower levels before the price surged to the circuit limit. This pattern often reflects a final burst of demand pushing the price to the ceiling, but with limited follow-through selling at that level.

Brief Fundamental Context

Gaudium IVF and Women Health Ltd operates in the Healthcare Services sector, a space that generally benefits from steady demand. However, the micro-cap status and recent price action suggest that the stock is still navigating volatility and has yet to establish a sustained uptrend. The current upper circuit move is more reflective of short-term market dynamics than a fundamental shift.

Conclusion: What the Circuit and Data Signal

The upper circuit hit at a 5% gain capped the session for Gaudium IVF and Women Health Ltd, with clear unfilled demand as buyers outnumbered sellers at the ceiling price. However, the falling delivery volumes and the stock trading below all major moving averages suggest that this move is more speculative than conviction-driven. The micro-cap status and limited liquidity further amplify the risk, as thin order books can exaggerate price moves and make it difficult to enter or exit positions without impacting the price. Investors should weigh these factors carefully — after a 5% single-day gain at upper circuit, is Gaudium IVF still worth considering or has the move already happened?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →